85 related articles for article (PubMed ID: 24866503)
1. Differential expression of stromal aromatase in obese females is regulated by DNA methylation.
Zeng XC; Ao X; Yang HF; Zhang GX; Li WH; Liu QL; Tang YL; Xie YC; He WG; Huang YN; Zhang L; Li RJ
Mol Med Rep; 2014 Aug; 10(2):887-90. PubMed ID: 24866503
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.
Ghosh S; Lu Y; Katz A; Hu Y; Li R
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E246-52. PubMed ID: 16940470
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
[TBL] [Abstract][Full Text] [Related]
4. An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells.
Izawa M; Harada T; Taniguchi F; Ohama Y; Takenaka Y; Terakawa N
Fertil Steril; 2008 May; 89(5 Suppl):1390-6. PubMed ID: 17662285
[TBL] [Abstract][Full Text] [Related]
5. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
[TBL] [Abstract][Full Text] [Related]
6. CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity.
Demura M; Bulun SE
Mol Cell Endocrinol; 2008 Feb; 283(1-2):127-32. PubMed ID: 18201819
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts.
Knower KC; To SQ; Simpson ER; Clyne CD
Mol Cell Endocrinol; 2010 Jun; 321(2):123-30. PubMed ID: 20211687
[TBL] [Abstract][Full Text] [Related]
8. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin and des-acyl ghrelin inhibit aromatase expression and activity in human adipose stromal cells: suppression of cAMP as a possible mechanism.
Docanto MM; Yang F; Callaghan B; Au CC; Ragavan R; Wang X; Furness JB; Andrews ZB; Brown KA
Breast Cancer Res Treat; 2014 Aug; 147(1):193-201. PubMed ID: 25056185
[TBL] [Abstract][Full Text] [Related]
11. Cell density is a critical determinant of aromatase expression in adipose stromal cells.
Ghosh S; Hu Y; Li R
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):231-6. PubMed ID: 19969081
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase.
Brown KA; Hunger NI; Docanto M; Simpson ER
Breast Cancer Res Treat; 2010 Sep; 123(2):591-6. PubMed ID: 20300828
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts.
Chand AL; Herridge KA; Howard TL; Simpson ER; Clyne CD
Steroids; 2011 Jul; 76(8):741-4. PubMed ID: 21392518
[TBL] [Abstract][Full Text] [Related]
14. IKKbeta mediates cell shape-induced aromatase expression and estrogen biosynthesis in adipose stromal cells.
Ghosh S; Choudary A; Ghosh S; Musi N; Hu Y; Li R
Mol Endocrinol; 2009 May; 23(5):662-70. PubMed ID: 19221050
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin promotes aromatase expression and estradiol production in human adipocytes.
Leitner L; Jürets A; Itariu BK; Keck M; Prager G; Langer F; Grablowitz V; Zeyda M; Stulnig TM
Breast Cancer Res Treat; 2015 Nov; 154(1):63-9. PubMed ID: 26482249
[TBL] [Abstract][Full Text] [Related]
16. Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer.
Wang X; Simpson ER; Brown KA
J Steroid Biochem Mol Biol; 2015 Sep; 153():35-44. PubMed ID: 26209254
[TBL] [Abstract][Full Text] [Related]
17. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
18. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
19. Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues.
Izawa M; Taniguchi F; Uegaki T; Takai E; Iwabe T; Terakawa N; Harada T
Fertil Steril; 2011 Jan; 95(1):33-9. PubMed ID: 20655525
[TBL] [Abstract][Full Text] [Related]
20. Methylseleninic acid is a novel suppressor of aromatase expression.
Gao R; Zhao L; Liu X; Rowan BG; Wabitsch M; Edwards DP; Nishi Y; Yanase T; Yu Q; Dong Y
J Endocrinol; 2012 Feb; 212(2):199-205. PubMed ID: 22128327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
